- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02829294
Evaluation of a Novel Product for the Removal of Impacted Human Cerumen (Earwax)
October 3, 2019 updated by: Dr. Joseph Griffin
This is a prospective, open-labeled clinical trial.
Subjects that qualify for enrollment and provide informed consent will be treated with a novel topical cerumen (earwax) removal product.
The primary goal of this pilot study is to gain an understanding of the safety and efficacy of this novel product.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This is a single center, single-arm, open-label trial.
Approximately 30 evaluable ears will be enrolled that have at least 50% cerumen impaction.
All ears/subjects will receive at least a single dose (approximately 1 - 2 mL) of the test product applied topically in the study ear canal.
The test product will be supplied from a qualified compounding pharmacy that receives a by-subject prescription from the investigator.
The subject will be dosed with the head tilted in order to keep the test product in the ear canal for 15 minutes.
At 5 and 10 minutes, subjects will be instructed to move their jaw up and down (and side to side) a few times and, manipulate/massage the ear canal by pressing between jawbone and ear lobe with a rotating motion for 10 seconds, which may aid in distribution of the test product in the ear canal.
Fifteen minutes after product instillation, it will be removed by having the subject tilt the head over a disposable container to catch the solution.
The ear canal will be irrigated (low pressure) with warm water and, the evaluator will try to visualize the tympanic membrane using an otoscope (before and after lavage).
The amount (change in area, volume and depth) of the tympanic membrane that can be visualized and the categorization of cerumen impaction (according to a 5 point scale) is the primary efficacy parameter of this study.
Efficacy will also be assessed using subjective questions (improvement and change in symptoms) that will be asked by the study staff and documented prior to the subject having any knowledge of the otoscope results (visualization of TP).
Study Type
Interventional
Enrollment (Actual)
19
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Plano, Texas, United States, 75026
- Legacy Medical Village
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Males or non-pregnant females ≥ 40 years of age at enrollment;
- Presence of excessive or impacted cerumen [excessive or impacted cerumen is identified as causing partial (> 50%) or complete occlusion of at least one ear canal when attempting to visualize the tympanic membrane];
- Willingness to participate in the study; or
- Mental aptitude to provide verbal and/or written informed consent without the aid of another.
Exclusion Criteria:
- Pregnant, breastfeeding, or unwilling to practice birth control during participation in the study (has been accustomed to birth control and will continue it up to and including Visit 2);
- Presence of a tympanostomy tube at any time during the previous 12 months;
- Presence of a non-intact tympanic membrane (TM);
- Presence of a known or suspected ear infection;
- Presence of known or suspected mastoiditis;
- Use of any ototopical drug or OTC product or earwax-removal product (with the exception of water or physiologic saline) during the preceding 3 days; or
- Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data (e.g. ear eczema or seborrhea).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Treatment
E002 - cerumen removal aid will be placed into the ear canal of enrolled subjects for 15 to 30 minutes
|
topical treatment
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percentage of Ears That Showed Change in Visualization of the Tympanic Membrane (Ear Drum) Following 15 or 30 Minutes of Using the Test Product
Time Frame: 15 and 30 minutes
|
Cerumen impaction will be graded following 15 and 30 minutes after using the test product in the external ear canal.
Cerumen impaction is graded by the % of the ear drum is visible using an otoscope.
Grade 5 (severe) = 76-100% of the ear drum is obstructed from view.
Grade 4 (moderate) = 51-75% of the ear drum is obstructed from view.
Grade 3 (mild) = 26-50% of the ear drum is obstructed from view.
Grade 2 = 3-25% of the ear drum is obstructed from view.
Grade 1 (normal) = less than 3% of the ear drum is obstructed from view.
|
15 and 30 minutes
|
Safety Measured by the Collection of Unsolicited Adverse Events Reported by Patients
Time Frame: After treatment
|
Ear canal specific safety evaluation, measured by physician, during the course of treatment up to 48 hours post treatment and collection of adverse events (related and non-related)
|
After treatment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Improvements in Ear Specific Clinical Symptoms After 1 or 2, 15 Minute Applications of E002
Time Frame: Immediately following 1 or 2 treatments
|
Collect symptom information prior to and post treatment with the novel test solution designed to help clean and clear the ear canal of debris including cerumen
|
Immediately following 1 or 2 treatments
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Joe Griffin, PhD, Eosera Inc
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2016
Primary Completion (Actual)
May 1, 2016
Study Completion (Actual)
July 1, 2016
Study Registration Dates
First Submitted
July 8, 2016
First Submitted That Met QC Criteria
July 8, 2016
First Posted (Estimate)
July 12, 2016
Study Record Updates
Last Update Posted (Actual)
October 4, 2019
Last Update Submitted That Met QC Criteria
October 3, 2019
Last Verified
October 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EOS-002
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cerumen Impaction of Both Ears
-
HL Healthcare LtdAKRN Scientific Consulting, S.L.Completed
-
Hospital Authority, Hong KongUnknownCerumen Impaction of Both EarsHong Kong
-
Orion Corporation, Orion PharmaCompletedCerumen Impaction of Both EarsLithuania
-
Sunnybrook Health Sciences CentreCompletedEustachian Tube Dysfunction | Eustachian Tube Dysfunction of Both EarsCanada
-
Columbia UniversityWithdrawnEustachian Tube Dysfunction | Eustachian Tube Dysfunction of Left Ear | Eustachian Tube Dysfunction of Right Ear (Diagnosis) | Eustachian Tube Dysfunction of Both Ears (Diagnosis)United States
-
Cliniques universitaires Saint-Luc- Université...Grand Hôpital de Charleroi; Université de Liège; Clinique Saint-Jean, Bruxelles; Clinique Saint Pierre OttigniesNot yet recruiting
-
Damascus UniversityCompletedImpaction of ToothSyrian Arab Republic
-
Farabi Eye HospitalUnknownKeratitis of Both Eyes
-
Instituto de Oftalmología Fundación Conde de ValencianaCompleted